ArticleRevista da Associacao Medica Brasileira (1992)2026
Anticholinergic burden and bone health in rheumatoid arthritis.
Article in Revista da Associacao Medica Brasileira (1992), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveRheumatoid arthritis is associated with osteoporosis and falls. While anticholinergic burden increases fracture risk in older adults, its contribution to bone health in rheumatoid arthritis is unclear. The aim of this study was to determine if anticholinergic burden is an independent risk factor for osteoporosis and fracture in rheumatoid arthritis.
methodsThis retrospective cohort study included 120 adults with rheumatoid arthritis. Cumulative anticholinergic burden was quantified using eight validated scales (anticholinergic burden, Anticholinergic Risk Scale, Anticholinergic Drug Scale, Clinician-rated Anticholinergic Scale, Anticholinergic Activity Scale, Anticholinergic Effect on Cognition Scale, Anticholinergic Loading Scale, and CRIDECO). Outcomes included lumbar spine and hip bone mineral density, Fracture Risk Assessment Tool 10-year fracture probabilities, and World Health Organization-defined osteoporosis. Fracture Risk Assessment Tool major and L1-L4 T-score models included age, body mass index, rheumatoid arthritis duration, anticholinergic burden Calc Score, and Anticholinergic Drug Scale Score, whereas the binary osteoporosis model included age, body mass index, comorbidity count, anticholinergic burden Calc Score, and Anticholinergic Drug Scale Score.
resultsIn unadjusted analyses, only Clinician-rated Anticholinergic Scale ≥1 was associated with osteoporosis (p=0.010), whereas the other thresholdbased scales were not. After adjustment for the covariates specified in each model, neither anticholinergic burden Calc Score nor Anticholinergic Drug Scale Score independently predicted Fracture Risk Assessment Tool major probability (p=0.415 and p=0.189), L1-L4 T-score (p=0.436 and p=0.291), or binary osteoporosis status (p=0.849 and p=0.653). Age remained the only independent predictor in the osteoporosis model (OR 1.083; 95%CI 1.019-1.151; p=0.010), whereas older age and lower body mass index predicted higher Fracture Risk Assessment Tool major probability.
conclusionIn rheumatoid arthritis, the apparent relationship between anticholinergic burden and osteoporosis is largely explained by age, body composition, and comorbidity-related prescribing. Although anticholinergic burden was not an independent fracture risk factor after adjustment, higher anticholinergic burden may still reflect greater prescribing complexity and comorbidity burden in rheumatoid arthritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.